After Hours Summary: CHRS +29.5%, CALL +17.4%, WYY +15.4%, RARE -19.7%, LPSN -17.1%, RAX -12.9% following earnings/guidance
After Hours Gainers:
Companies trading higher in after hours in reaction to earnings: CHRS +29.5%, CALL +17.4%, WYY +15.4%, PRSC +12.4%, VRTU +9.1%, ORIG +7.8%, PLAB +6%, EVDY +5.7%, NSPH +5.1%, PRKR +4.4%, SCLN +4.3%, XON +4.2%, CPRX +3.5%, ARNA +3.1%, PFSW +3%, USAT +2.8%, OPHT +2.5%, PRTS +1.5%, JUNO +1.4%, CYTX +1.3%, TCRD +1.3%, OMER +0.9%, SCAI +0.8%, PINC +0.4%, CIM +0.4%
Companies trading higher in after hours in reaction to news: EOX +8.5% (entered into definitive agreement to acquire core Delaware Basin acreage in Lea and Eddy Counties, New Mexico for $75.2 mln; increases FY15 production and CapEx guidance), NAVB +4.6% (secured $60 Million loan with CRG; funding to support Lymphoseek commercialization and advancement of development pipeline), ARNA +3.1% (co and Roivant Sciences enter into collaboration for nelotanserin, a novel inverse agonist of the 5-HT2A receptor; co also reported earnings), HK +3.1% (Franklin Resources disclosed 13.5% passive stake in 13G filing), CDK +2.5% (Elliott Associates disclosed 7.6% active stake in 13D filing)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: RARE -19.7%, LPSN -17.1%, ATHX -13%, RAX -12.9%, CLNE -11.2%, DEPO -9.1%, UNIS -7.6%, IPXL -7.3%, MTZ -6.7%, SYN -5.8%, AKAO -5.3%, ARWR -4%, DRYS -4%, LDR -3.9%, OME -3.4%, JOBS -3.3%, OVAS -2.9%, PBYI -2.5%, ZGNX -2.2%, PVA -1.8%, OPK -1.8%, DRNA -1.6%, MDR -1.6%, MBI -1.1%, TWER -1.1%, MR -1.1%, TEP -1%, GBDC -0.9%, FXEN -0.9%
Companies trading lower in after hours in reaction to news: NOR -18.7% (announced a 22.84 mln share, secondary common stock offering, by selling stockholders affiliated with Apollo Global Management), NLNK -18.2% (co's IMPRESS Phase 3 pancreatic cancer trial with Algenpantucel-L to continue following second interim analysis), XONE -2.7% (reported a delay in filing its form 10-Q for Quarter ending March, 2015), CUBI -0.8% (priced its 2 mln share, fixed-to-floating rate non-cumulative perpetual preferred stock, series C at $25/share)